Republic of Korea vs Lao People's Democratic Republic: Previously treated cases tested for RR-/MDR-TB
Republic of Korea
100.0%
in 2024
Lao People's Democratic Republic
100.0%
in 2024
Republic of Korea rank
1st
Lao People's Democratic Republic rank
1st
Previously treated cases tested for RR-/MDR-TB over time
- Republic of Korea
- Lao People's Democratic Republic
How they compare
Republic of Korea currently reports 100.0% against 100.0% in Lao People's Democratic Republic, a difference of 0.0%.
The two have swapped places 2 times across 12 shared years of data; in 2013 it was Lao People's Democratic Republic ahead.
Republic of Korea ranks 1st and Lao People's Democratic Republic ranks 1st of 180 countries.
Across the 2 decades both report, Republic of Korea averaged higher in 1 and Lao People's Democratic Republic in 1.
Head to head by decade
| Decade | Republic of Korea | Lao People's Democratic Republic | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 61.6% | 54.4% | 7.1% | Republic of Korea |
| 2020s | 92.0% | 100.0% | 8.0% | Lao People's Democratic Republic |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher previously treated cases tested for rr-/mdr-tb, Republic of Korea or Lao People's Democratic Republic?
- Republic of Korea, at 100.0% against 100.0% in Lao People's Democratic Republic as of 2024.
- What is the difference in previously treated cases tested for rr-/mdr-tb between Republic of Korea and Lao People's Democratic Republic?
- 0.0%, with Republic of Korea ahead.
- How many years of comparable data are there for Republic of Korea and Lao People's Democratic Republic?
- 12 years are reported by both, from 2013 to 2024.
- How do Republic of Korea and Lao People's Democratic Republic rank globally for previously treated cases tested for rr-/mdr-tb?
- Republic of Korea ranks 1st and Lao People's Democratic Republic ranks 1st of 180 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as Previously treated cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.